These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1897195)

  • 1. [Selective inhibition of monoamine oxidase in bovine brain by befol and moclobemide].
    Moskvitina TA; Gankina EM; Val'dman AV
    Vopr Med Khim; 1991; 37(2):49-51. PubMed ID: 1897195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The action of befol and its derivatives on monoamine oxidase of different origins].
    Gol'dina OA; Moskvitina TA; Gankina EM; Kirkel' AZ; Kamyshanskaia NS; Lopatina KI; Sokolova TV; Zagorevskiĭ VA; Val'dman AV; Gorkin VZ
    Biull Eksp Biol Med; 1991 Mar; 111(3):279-80. PubMed ID: 2054504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of various antidepressive agents on brain monoamine oxidase activity].
    Gankina EM; Moskvitina TA; Gorkin VZ; Val'dman AV
    Biull Eksp Biol Med; 1982 Nov; 94(11):29-31. PubMed ID: 7150732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of benzamide derivatives on rat brain monoamine oxidase activity in vitro].
    Gol'dina OA; Zagorevskiĭ VA; Lopatina KI; Sokolova TV; Gankina EM
    Biull Eksp Biol Med; 1986 Aug; 102(8):170-2. PubMed ID: 3742029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
    Volz HP; Gleiter CH; Möller HJ
    Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The advent of a new generation of monoamine oxidase inhibitor antidepressants: pharmacologic studies with moclobemide and brofaromine.
    Lavian G; Finberg JP; Youdim MB
    Clin Neuropharmacol; 1993; 16 Suppl 2():S1-7. PubMed ID: 8313392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the new MAO-A inhibitors moclobemide, brofaromine and toloxatone with tranylcypromine in an animal experiment: significance for clinical practice].
    Da Prada M; Keller HH; Kettler R
    Psychiatr Prax; 1989 Aug; 16 Suppl 1():18-24. PubMed ID: 2587673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
    Da Prada M; Kettler R; Keller HH; Burkard WP; Muggli-Maniglio D; Haefely WE
    J Pharmacol Exp Ther; 1989 Jan; 248(1):400-14. PubMed ID: 2783611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine oxidase-A inhibitors and dopamine metabolism in rat caudatus: evidence that an increased cytosolic level of dopamine displaces reversible monoamine oxidase-A inhibitors in vivo.
    Colzi A; D'Agostini F; Cesura AM; Borroni E; Da Prada M
    J Pharmacol Exp Ther; 1993 Apr; 265(1):103-11. PubMed ID: 8473998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-clinical pharmacology of moclobemide. A review of published studies.
    Burkard WP; Da Prada M; Keller HH; Kettler R; Haefely W
    Br J Psychiatry Suppl; 1989 Oct; (6):84-8. PubMed ID: 2695131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Selective inhibition by pyrazidol of monoamine oxidase type A in different human and animal tissues].
    Verevkina IV; Asnina VV; Gorkin VZ; Mashkovskiĭ MD
    Vopr Med Khim; 1983; 29(5):118-23. PubMed ID: 6649522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monoamine oxidase inhibition by pyrrole quinoline derivatives].
    Moskvitina TA; Shabunova VP; Akhvlediani RN; Suvorov NN
    Biokhimiia; 1988 May; 53(5):714-20. PubMed ID: 3167119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of monoamine oxidase-A inhibition by moclobemide in vitro and ex vivo in rats.
    Kettler R; Da Prada M; Burkard WP
    Acta Psychiatr Scand Suppl; 1990; 360():101-2. PubMed ID: 2248058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibition of noradrenaline deamination by antidepressants].
    Moskvitina TA; Gankina EM; Val'dman AV
    Biull Eksp Biol Med; 1986 Jul; 102(7):44-6. PubMed ID: 3730591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moclobemide effects on prolactin plasma levels in healthy individuals: the hormonal increase induced by a single dose is maintained during a 4-week period of drug intake.
    Juruena MF; Pires ML; Calil HM
    Int Clin Psychopharmacol; 1997 Nov; 12(6):317-21. PubMed ID: 9547133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-lasting and reversible inhibition of monoamine oxidase-A by moclobemide.
    Da Prada M; Kettler R; Keller HH; Burkard WP
    Acta Psychiatr Scand Suppl; 1990; 360():103-5. PubMed ID: 2248059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cheese effect and new reversible MAO-A inhibitors. Proceedings of the round table of the International Conference on New Directions in Affective Disorders, Jerusalem, April 5-9, 1987.
    J Neural Transm Suppl; 1988; 26():1-136. PubMed ID: 3162947
    [No Abstract]   [Full Text] [Related]  

  • 18. cAMP-dependent phosphorylation system after short and long-term administration of moclobemide.
    Mori S; Zanardi R; Popoli M; Garbini S; Brunello N; Smeraldi E; Racagni G; Perez J
    J Psychiatr Res; 1998; 32(2):111-5. PubMed ID: 9694007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
    Youdim MB; Weinstock M
    Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mode of action and characteristics of monoamine oxidase-A inhibition by moclobemide.
    Cesura AM; Kettler R; Imhof R; Da Prada M
    Psychopharmacology (Berl); 1992; 106 Suppl():S15-6. PubMed ID: 1546132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.